Seelos Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

Seelos Therapeutics

01/05/2021 02:00

* Seelos Therapeutics Inc  SEEL.OQ  reported a quarterly
adjusted loss of 28 cents​​ per share for the quarter ended
in March. The mean expectation of three analysts for the quarter
was for a loss of 9 cents per share.
* Revenue was $0.00​​;  analysts expected $0.00.
* Seelos Therapeutics Inc's reported EPS for the quarter was a
loss of 28 cents​.
* The mean earnings estimate of analysts had fallen by
about 5.9% in the last three months.​ 
* In the last 30 days one analyst negatively revised an earnings
estimate and  
* Seelos Therapeutics Inc shares had risen by 24.6% this
quarter and gained 293.7% so far this year.
* The company reported a quarterly loss of $19.12 million.
* Wall Street's median 12-month price target for Seelos
Therapeutics Inc is $13.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated May 1 at 01:00 a.m. GMT. ​All
figures in US Dollars.​